|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 14723864.6 (espacenet) (Federated) (European Patent Register), 20140509 | | Patent/reg. no. and date | DK/EP 2994148, 20170201 | | Publication date | 20160316 | | Priority no. and date | GB 201308325, 20130509 | | EP pub. no. and date |
EP 2994148 20160316 | | Effective date | | | Applicant/owner | Immodulon Therapeutics, 475 Salisbury House
London Wall
London
EC2M 5QQ, GB | | Applicant ref. no. | P60982DK01 | | Inventor | HAGEMANN, Thorsten, Queen Mary&Westfield College University of London
The Joint Research&Development Office
The QMI Building
5 Walden Street
Whitechapel
London E1 2EF, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/436 (2006.01) , A61K 35/74 (2015.01) , A61P 35/00 (2006.01) | | Title | CANCERTERAPI | | Int. application no. | GB2014051421 | | Int. publication no. | WO2014181121 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
